Pierre Meulien, director of the Innovative Medicines Initiative wants to see pooling of international research efforts to help curb the spread of COVID-19 and develop treatments for the respiratory infection it causes
Cristian-Silviu Bușoi says there is a “theoretical risk” that a delayed budget would have a “negative impact” on the start of EU research programmes in January 2021
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.